Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – A systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference62 articles.
1. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac outcomes Trial–Lipid lowering arm (ASCOT-LLA): a multicentre randomis;Sever;Lancet,2003
2. MRC/BHF heart Protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial;Collins;Lancet,2003
3. Non-adherence to statin therapy: a major challenge for preventive cardiology;Bates;Expert Opin. Pharmacother.,2009
4. Use of complementary therapies in patients with cardiovascular disease;Yeh;Am. J. Cardiol.,2006
5. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients–the PRIMO study;Bruckert;Cardiovasc. Drugs Ther.,2005
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of the combination of red yeast rice-containing commercial Chinese polyherbal preparation with statins for dyslipidemia: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-07-23
2. Natural Products;APhA OTC - Complementary Therapies;2024-07
3. Integrating untargeted and pseudotargeted metabolomics and network analysis reveals the interventional effects of red yeast rice on rat serum metabolites;Food Bioscience;2024-06
4. Metabolomic insights into Monascus‐fermented rice products: Implications for monacolin K content and nutritional optimization;Food Science & Nutrition;2024-05-13
5. Safety and Efficacy of the Consumption of the Nutraceutical “Red Yeast Rice Extract” for the Reduction of Hypercholesterolemia in Humans: A Systematic Review and Meta-Analysis;Nutrients;2024-05-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3